Oct. 16, 2009 — Eleven children died of H1N1 swine flu final week, raising the October child/teen death toll to 43 — more pediatric passings in one month than seen in a bad September-to-May flu season.
Overall, 86 children and high schoolers beneath age 18 have died from the H1N1 swine flu. Half the passings have been in teens between the ages of 12 and 17.
“These are exceptionally calming insights and, unfortunately, they are likely to increase,” Anne Schuchat, MD, director of the CDC’s National Center for Immunization and Respiratory Diseases, said at a news conference.
Of the 43 pediatric H1N1 swine flu passings since Sept. 30:
Three deaths were in children beneath age 2. Five passings were in children ages 2 to 4. 16 deaths were in children ages 5 to 11. 19 deaths were in high schoolers ages 12 to 17.
“This is often a really brisk number for a entire season. From September all the way to May you would have only 40 or 50 pediatric passings, and in fair one month’s time we have had that numerous,” Schuchat said. “Of course, a few have underlying conditions, such as strong dystrophy and cerebral paralysis, but some have been totally sound and this really hits home for individuals.”
She stressed the caution signs for parents to look out for:
Trouble waking Not taking nourishing well Trouble breathing A blue or grayish tint to the skin Ailment that gets better but begins getting more awful.
Child deaths aren’t the only sign that H1N1 swine flu is on the rise. Final week, widespread flu was widespread in 41 states, up from 37 states in the previous week. And deaths ascribed to pneumonia and flu — a measure of flu severity — went over the “plague threshold” for the first time this drop.
“It is phenomenal for this time of year for the entire nation to see such levels of influenza action,” Schuchat said.
Slowdown in H1N1 Swine Flu Antibody Generation
In the interim, producers are having a hard time making as much H1N1 swine flu immunization as they’d anticipated.
The new prediction is that there will be 28 million to 30 million vaccine measurements accessible for order by the end of October — down from a recent expectation of 40 million doses by that time.
As of Oct. 14, the U.S. had 11.4 million dosages on hand, and states had placed orders for 8 million measurements — 2.2 million more measurements than had been requested fair two days before.
“We wish we had more, but it doesn’t see like we will make our estimates for the end of the month,” Schuchat said. “Generation estimates will be lower, but do still eventually expect to have the large number of measurements we were talking approximately. But next couple of weeks will proceed to be a slow start.”
By mid-November, Schuchat said, it’s trusted that the antibody will be readily accessible in most locations. By the end of December, it’s trusted that all 250 million dosages the U.S. has acquired will be delivered.